High-dose therapy with autologous PBSC transplantation in the front-line treatment of Waldenstrom's macroglobulinemia

Bone Marrow Transplantation

Volumn 43, Issue 7, 2009, Pages 587-588

  Caravita, T ^a   Siniscalchi, A ^a   Tendas, A ^a   Cupelli, L ^a   Dentamaro, T ^a   Natale, G ^a   Spagnoli, A ^a   de Fabritiis, P ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; AUTOGRAFT; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPENIA; DRUG EFFICACY; DRUG MEGADOSE; FEASIBILITY STUDY; HUMAN; LYMPHOCYTIC INFILTRATION; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPHIL COUNT; PRIORITY JOURNAL; QUALITY OF LIFE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; WALDENSTROEM MACROGLOBULINEMIA; WHOLE BODY RADIATION;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; HUMANS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; WALDENSTROM MACROGLOBULINEMIA;

EID: 64949113425     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.360     Document Type: Article

References (10)

1. Morel P, Duhamel A, Gobbi P, Dimopoulos M, Dhodapkar M, McCoy J et al International Prognostic Scoring System (IPSS) forWa ldenstrom's macroglobulinemia (WM). Blood 2006; 108: 42a (abstract 127).
2. Vijay A, Gertz MA. Waldenstrom macroglobulinemia. Blood 2007; 109: 5096-5103.
3. Kimby E, Treon SP, Anagnostopoulos A, Dimopoulos M, Garcia-Sanz R, Gertz MA et al. Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia. Clin Lymphoma Myeloma 2006; 6: 380-383.
4. Treon SP, Gertz MA, Dimopoulos M, Anagnostopoulos A, Blade J, Branagan AR et al. Update on treatment recommendations from the Third International Workshop on Waldenstrom's Macroglobulinemia. Blood 2006; 107: 3442-3446.
5. Dimopoulos MA, Anagnostopoulos A. Treatment of Waldenstrom's Macroglobulinemia. Curr Treat Options Oncol 2007; 8: 144-153.
6. Anagnostopoulos A, Dimopoulos MA, Aleman A, Weber D, Alexanian R, Champlin R et al. High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia. Bone Marrow Transplant 2001; 27: 1027-1029.
7. Desikan R, DhodapkarM, Siegel D, Fassas A, Singh J, Singhal S et al High-dose therapy with autologous haemopoietic stem cell support for Waldenstrom's macroglobulinaemia. Br J Haematol 1999; 105: 993-996.
8. Dreger P, Glass B, Kuse R, Sonnen R, von Neuhoff N, Bolouri H et al Myeloablative radiochemotherapy followed by reinfusion of purged autologous stem cells for Waldenstrom's macroglobulinaemia. Br J Haematol 1999; 106: 115-118.
9. Anagnostopoulos A, Hari PN, Perez WS, Ballen K, Bashey A, Bredeson CN et al. Autologous orallogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia. Biol Blood Marrow Transplant 2006; 12: 845-854.
10. Buske C, Martin H, Dreyling MH, Eimermacher H, Boeck HP, Pfreundschuh M et al. Combined immuno-chemotherapy (R-CHOP) results in significantly superior response rates and time to treatment failure in first line treatment of patients with lymphomplasmocytoid/ic immunocytoma (LP-IC) - results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). ASH Annu Meet Abstracts 2004; 104: 162.